Announced Mon, 15 Jun · 19:28 IST
Trading Window Closure for Q1 FY26 Financial Results
Compliance View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹8400.00
prior close
₹8450.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.6-0.6-0.7+1.5+1.4+0.7+2.1+1.0+0.5-3.0-3.1——
Up moveDown movePending
AI summary
AstraZeneca Pharma India has closed its trading window from June 16, 2026, under SEBI insider trading rules. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending June 30, 2026 (Q1 FY27). During this period, insiders, directors, and employees with access to unpublished financial data are restricted from trading the company's shares.
Likely market impact
Routine compliance action. Insiders cannot trade shares until 48 hours after Q1 results are announced. No material impact on retail investors.